Xvivo Perfusion AB

0RKL•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£306.80

+1.93%

End of day

Market Cap

$7.97B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	10.22	—	—	—	10.22
Calmar	—	—	14.28	—	—	—	14.28
Sharpe	85.38	—	5.03	—	—	—	25.12
Omega	—	8.02	1.76	—	—	—	4.26
Martin	—	—	22.79	—	—	—	22.79
Ulcer	0.00	0.91	12.46	—	—	—	6.53

Also Listed On

XVIVO.ST

Nasdaq Stockholm · SEK

$9.37B

XVIPF.US

United States · USD

Xvivo Perfusion AB (0RKL) Price Performance

Xvivo Perfusion AB (0RKL) trades on London Stock Exchange in GBP. The stock currently trades at GBP306.80, up 1.93% from the previous close.

Over the past year, 0RKL has traded between a low of GBP175.80 and a high of GBP306.80. The stock has gained 39.8% over this period. It is currently 74.5% above its 52-week low.

Xvivo Perfusion AB has a market capitalization of $7.97B.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): $812.16M
EBITDA: $129.31M
Profit Margin: 3.10%
EPS (TTM): 0.24
Book Value: 67.09

Technical Indicators

52 Week High: £308.60
52 Week Low: £172.90
50 Day MA: £210.89
200 Day MA: N/A
Beta: 1.40

Valuation

Trailing P/E: 1270.04
Forward P/E: N/A
Price/Sales: 9.82
Price/Book: 4.49
Enterprise Value: $9.31B